Stem-cell based therapies for brain tumors

Current Opinion in Molecular Therapeutics

Volumn 10, Issue 4, 2008, Pages 334-342

  Yip, S ^a   Shah, K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain tumor; Molecular imaging; Stem cell; Therapeutic; Viral vector

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTERFERON; BEVACIZUMAB; CAMPTOTHECIN; CEDIRANIB; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GANCICLOVIR; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 4; IRINOTECAN; PEROXISOMAL ASSEMBLY FACTOR; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; BRAIN NERVE CELL; BRAIN TUMOR; CANCER CELL DESTRUCTION; CELL DIFFERENTIATION; CELL FATE; CELL MIGRATION; CELL RENEWAL; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC VALUE; DNA MODIFICATION; DRUG DELIVERY SYSTEM; DRUG MECHANISM; GLIOMA; HUMAN; IMMUNOMODULATION; NEURAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACODYNAMICS; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; SUICIDE GENE THERAPY; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BRAIN NEOPLASMS; HUMANS; NEURONS; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE THERAPY;

EID: 49249120070     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS et al: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project. J Neurosurg (2003) 99(3):467-473.
2. Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER: Patterns of care for adults with newly diagnosed malignant glioma. J Am Med Assoc (2005) 293(5):557-564.
3. Claes A, Idema AJ, Wesseling P: Diffuse glioma growth: A guerilla war. Acta Neuropathol (Berl) (2007) 114(5):443-458.
4. Parsa AT, Waldron JS, Panner A, Crane CA, Parney IF, Barry JJ, Cachola KE, Murray JC, Tihan T, Jensen MC, Mischel PS et al: Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med (2007) 13(1):84-88.
5. Fecci PE, Mitchell DA, Whitesides JF, Xie W, Friedman AH, Archer GE, Herndon JE 2nd, Bigner DD, Dranoff G, Sampson JH: Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res (2006) 66(6):3294-3302.
6. Aghi M, Chiocca EA: Gene therapy for glioblastoma. Neurosurg Focus (2006) 20(4):E18.
7. Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN: Molecularly targeted therapy for malignant glioma. Cancer (2007) 110(1):13-24.
8. Gage FH: Mammalian neural stem cells. Science (2000) 287(5457):1433-1438. •• A classic review on the developmental biology of neural stem cells.
9. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO, Snyder EY: Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA (2000) 97(23):12846-12851. •• The first comprehensive demonstration of gliomatrophic migration of murine and human NSCs toward glioma cells and the successful delivery of their therapeutic payload to tumor deposits in vivo.
10. Tang Y, Shah K, Messerli SM, Snyder E, Breakefield X, Weissleder R: In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther (2003) 14(13):1247-1254.
11. Emsley JG, Mitchell BD, Kempermann G, Macklis JD: Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog Neurobiol (2005) 75(5):321-341.
12. Evans MJ, Kaufman MH: Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 292(5819):154-156.
13. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science (1998) 282(5391):1145-1147.
14. Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, Thomson JA: Feeder-independent culture of human embryonic stem cells. Nat Methods (2006) 3(8):637-646.
15. Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, Daigh CA, Conard KR, Piekarczyk MS, Llanas RA, Thomson JA: Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol (2006) 24(2):185-187.
16. Sanai N, Tramontin AD, Quiñones-Hinojosa A, Barbaro NM, Gupta N, Kunwar S, Lawton MT, McDermott MW, Parsa AT, Manuel-Garcia Verdugo J, Burger MS et al: Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 427(6976):740-744. • This study confirmed the presence of NSCs in the adult human brain and showed that the lack of an established migratory path could affect endogenous migration of NSCs to the tumor.
17. Lee A, Kessler JD, Read TA, Kaiser C, Corbeil D, Huttner WB, Johnson JE, Wechsler-Reya RJ: Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci (2005) 8(6):723-729.
18. Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendoubi M, Sidman RL, Wolfe JH, Kim SU, Snyder EY: Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol (1998) 16(11):1033-1039. • This study showed that exogenous NSCs respond to and develop according to the local microenvironmental milieu.
19. Ostenfeld T, Caldwell MA, Prowse KR, Linskens MH, Jauniaux E, Svendsen CN: Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol (2000) 164(1):215-226.
20. Colombo E, Giannelli SG, Galli R, Tagliafico E, Foroni C, Tenedini E, Ferrari S, Ferrari S, Corte G, Vescovi A, Cossu G, Broccoli V: Embryonic stem-derived versus somatic neural stem cells: A comparative analysis of their developmental potential and molecular phenotype. Stem Cells (2006) 24(4):825-834.
21. Jiang Y, Henderson D, Blackstad M, Chen A, Miller RF, Verfaillie CM: Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc Natl Acad Sci USA (2003) 100(Suppl 1):11854-11860.
22. Kögler G, Sensken S, Airey JA, Trapp T, Müschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S et al: A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 200(2):123-135.
23. Joannides A, Gaughwin P, Schwiening C, Majed H, Sterling J, Compston A, Chandran S: Efficient generation of neural precursors from adult human skin: Astrocytes promote neurogenesis from skin-derived stem cells. Lancet (2004) 364(9429):172-178.
24. Safford KM, Safford SD, Gimble JM, Shetty AK, Rice HE: Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells. Exp Neurol (2004) 187(2):319-328.
25. Snyder EY, Deitcher DL, Walsh C, Arnold-Aldea S, Hartwieg EA, Cepko CL: Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell (1992) 68(1):33-51.
26. Cacci E, Villa A, Parmar M, Cavallaro M, Mandahl N, Lindvall O, Martinez-Serrano A, Kokaia Z: Generation of human cortical neurons from a new immortal fetal neural stem cell line. Exp Cell Res (2007) 313(3):588-601.
27. Roy NS, Nakano T, Keyoung HM, Windrem M, Rashbaum WK, Alonso ML, Kang J, Peng W, Carpenter MK, Lin J, Nedergaard M, Goldman SA: Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord. Nat Biotechnol (2004) 22(3):297-305.
28. Richardson RM, Nguyen B, Holt SE, Broaddus WC, Fillmore HL: Ectopic telomerase expression inhibits neuronal differentiation of NT2 neural progenitor cells. Neurosci Lett (2007) 421(2):168-172.
29. Martino G, Pluchino S: The therapeutic potential of neural stem cells. Nat Rev Neurosci (2006) 7(5):395-406.
30. Bai Y, Hu Q, Li X, Wang Y, Lin C, Shen L, Li L: Telomerase immortalization of human neural progenitor cells. Neuroreport (2004) 15(2):245-249.
31. De Filippis L, Lamorte G, Snyder EY, Malgaroli A, Vescovi AL: A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem Cells (2007) 25(9):2312- 2321.
32. Consiglio A, Gritti A, Dolcetta D, Follenzi A, Bordignon C, Gage FH, Vescovi AL, Naldini L: Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc Natl Acad Sci USA (2004) 101(41):14835-14840. • This study demonstrated successful lentiviral transfections of NSCs in vivo.
33. Dolcetta D, Perani L, Givogri MI, Galbiati F, Amadio S, Del Carro U, Finocchiaro G, Fanzani A, Marchesini S, Naldini L, Roncarolo MG, Bongarzone E: Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain. J Gene Med (2006) 8(8):962-971.
34. Geraerts M, Eggermont K, Hernandez-Acosta P, Garcia-Verdugo JM, Baekelandt V, Debyser Z: Lentiviral vectors mediate efficient and stable gene transfer in adult neural stem cells in vivo. Hum Gene Ther (2006) 17(6):635-650.
35. Capowski EE, Schneider BL, Ebert AD, Seehus CR, Szulc J, Zufferey R, Aebischer P, Svendsen CN: Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J Neurosci Methods (2007) 163(2):338-349.
36. Wong LF, Goodhead L, Prat C, Mitrophanous KA, Kingsman SM, Mazarakis ND: Lentivirus-mediated gene transfer to the central nervous system: Therapeutic and research applications. Hum Gene Ther (2006) 17(1):1-9.
37. Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Del Carro U, Amadio S, Bergami A, Furlan R et al: Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature (2003) 422(6933):688-694.
38. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res (2005) 65(8):3307-3318.
39. Dickson PV, Hamner JB, Burger RA, Garcia E, Ouma AA, Kim SU, Ng CY, Gray JT, Aboody KS, Danks MK, Davidoff AM: Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-β and restricts tumor growth in a murine model of disseminated neuroblastoma. J Pediatr Surg (2007) 42(1):48-53.
40. Takeuchi H, Natsume A, Wakabayashi T, Aoshima C, Shimato S, Ito M, Ishii J, Maeda Y, Hara M, Kim SU, Yoshida J: Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. Neurosci Lett (2007) 426(2):69-74.
41. Mueller FJ, McKercher SR, Imitola J, Loring JF, Yip S, Khoury SJ, Snyder EY: At the interface of the immune system and the nervous system: How neuroinflammation modulates the fate of neural progenitors in vivo. Ernst Schering Res Found Workshop (2005) 53:83-114.
42. Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, Salani G, Martinello M, Cattalini A, Bergami A, Furlan R, Comi G et al: Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature (2005) 436(7048):266-271.
43. Shah K, Bureau E, Kim DE, Yang K, Tang Y, Weissleder R, Breakefield XO: Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol (2005) 57(1):34-41. •• The first demonstration of the potential of NSCs as an advanced diagnostic imaging tool in gliomas.
44. Shah K, Hingtgen S, Kasmieh R, Figueiredo JL, Breakefield XO, Martinez-Serrano A, Weissleder R: Novel bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J Neurosci (2008) 28(17):4406-4413.
45. Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, Langer R, Snyder EY: Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA (2002) 99(5):3024-3029.
46. Chu K, Kim M, Jung KH, Jeon D, Lee ST, Kim J, Jeong SW, Kim SU, Lee SK, Shin HS, Roh JK: Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats. Brain Res (2004) 1023(2):213-221.
47. Wong AM, Hodges H, Horsburgh K: Neural stem cell grafts reduce the extent of neuronal damage in a mouse model of global ischaemia. Brain Res (2005) 1063(2):140-150.
48. Dietrich J, Kempermann G: Role of endogenous neural stem cells in neurological disease and brain repair. Adv Exp Med Biol (2006) 557:191-220.
49. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY, Khoury SJ: Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA (2004) 101(52):18117-18122.
50. Mueller FJ, Serobyan N, Schraufstatter IU, DiScipio R, Wakeman D, Loring JF, Snyder EY, Khaldoyanidi SK: Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins. Stem Cells (2006) 24(11):2367-2372.
51. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA: A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA (2003) 100(23):13513-13518.
52. Gilbertson RJ, Rich JN: Making a tumour's bed: Glioblastoma stem cells and the vascular niche. Nat Rev Cancer (2007) 7(10):733-736.
53. Ehtesham M, Yuan X, Kabos P, Chung NH, Liu G, Akasaki Y, Black KL, Yu JS: Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia (2004) 6(3):287-293.
54. Shah K: Neural stem cells and armed derivatives: Fate and therapeutic potential in the brain. Gene Ther Regulat (2007) 3(1):91-109.
55. Yip S, Sidman RL, Snyder E: Stem cells for targeting CNS malignancy. In: Principles of Molecular Neurosurgery. Freese A, Simeone FA, Leone P, Janson C (Eds), Karger Publishers, Basel, Switzerland (2005) 18:624-644.
56. Yip S, Sabetrasekh R, Sidman RL, Snyder EY: Neural stem cells as novel cancer therapeutic vehicles. Eur J Cancer (2006) 42(9):1298-1308.
57. Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D, Galli R, Selleri S, Di Meco F, De Fraja C, Vescovi A et al: Gene therapy of experimental brain tumors using neural progenitor. Nat Med (2000) 6(4):447-450. • An early study that demonstrated the gliomatropic behavior of NSCs and their potential as a therapeutic tool.
58. Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, Yu JS: Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res (2002) 62(24):7170-7174.
59. Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS: The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res (2002) 62(20):5657-5663.
60. Ehtesham M, Samoto K, Kabos P, Acosta FL, Gutierrez MA, Black KL, Yu JS: Treatment of intracranial glioma with in situ interferon-γ and tumor necrosis factor-α gene transfer. Cancer Gene Ther (2002) 9(11):925-934.
61. Li S, Gao Y, Tokuyama T, Yamamoto J, Yokota N, Yamamoto S, Terakawa S, Kitagawa M, Namba H: Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett (2007) 251(2):220-227.
62. Herrlinger U, Woiciechowski C, Sena-Esteves M, Aboody KS, Jacobs AH, Rainov NG, Snyder EY, Breakefield XO: Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther (2000) 1(4):347-357.
63. Uhl M, Weiler M, Wick W, Jacobs AH, Weller M, Herrlinger U: Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas. Biochem Biophys Res Commun (2005) 328(1):125-129.
64. Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N, Namba H: Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene. Oncology (2005) 69(6):503-508.
65. Aboody KS, Najbauer J, Schmidt NO, Yang W, Wu JK, Zhuge Y, Przylecki W, Carroll R, Black PM, Perides G: Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol (2006) 8(2):119-126.
66. Okada H, Pollack IF: Cytokine gene therapy for malignant glioma. Expert Opin Biol Ther (2004) 4(10):1609-1620.
67. Shimamura T, Husain SR, Puri RK: The IL-4 and IL-13 Pseudomonas exotoxins: New hope for brain tumor therapy. Neurosurg Focus (2006) 20(4):E11.
68. Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A: Interleukin-12: Biological properties and clinical application. Clin Cancer Res (2007) 13(16):4677-4685.
69. Spagnolo A, Glick RP, Lin H, Cohen EP, Feinstein DL, Lichtor T: Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-γ thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts. J Neurosurg (2007) 106(2):299-305.
70. Yang SY, Liu H, Zhang JN: Gene therapy of rat malignant gliomas using neural stem cells expressing IL-12. DNA Cell Biol (2004) 23(6):381-389.
71. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity (1995) 3(6):673-682.
72. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT: TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL. EMBO J (1997) 16(17):5386-5397.
73. Pollack IF, Erff M, Ashkenazi A: Direct stimulation of apoptotic signaling by soluble Apo2L/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin Cancer Res (2001) 7(5):1362-1369.
74. Shah K, Tung CH, Yang K, Weissleder R, Breakefield XO: Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy. Cancer Res (2004) 64(9):3236-3242.
75. Shah K, Tung CH, Breakefield XO, Weissleder R: In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. Mol Ther (2005) 11(6):926-931.
76. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K: MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res (2007) 67(19):8994-9000. • The first study of combinatorial therapy using TRAIL-secreting NSCs and miRNA inhibitors in a mouse model of brain tumors.
77. Kock N, Kasmieh R, Weissleder R, Shah K: Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia (2007) 9(5):435-442.
78. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT: Angiogenesis in brain tumours. Nat Rev Neurosci (2007) 8(8):610-622.
79. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M et al: AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell (2007) 11(1):83-95.
80. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M et al: Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol (2007) 25(30):4722-4729.
81. Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al-Hashem R, Kim SU, Black PM, Carroll RS: PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res (2005) 11(16):5965- 5970.
82. Pisati F, Belicchi M, Acerbi F, Marchesi C, Giussani C, Gavina M, Javerzat S, Hagedorn M, Carrabba G, Lucini V, Gaini SM et al: Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models. Cancer Res (2007) 67(7):3054-3063.
83. Müller FJ, Snyder EY, Loring JF: Gene therapy: Can neural stem cells deliver? Nat Rev Neurosci (2006) 7(1):75-84.
84. Yandava BD, Billinghurst LL, Snyder EY: "Global" cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA (1999) 96(12):7029-7034.
85. Snyder EY, Taylor RM, Wolfe JH: Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature (1995) 374(6520):367-370.
86. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY: Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol (2002) 20(11):1103-1110.
87. Redmond DE Jr, Bjugstad KB, Teng YD, Ourednik V, Ourednik J, Wakeman DR, Parsons XH, Gonzalez R, Blanchard BC, Kim SU, Gu Z et al: Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA (2007) 104(29):12175-12180.
88. Sanberg PR: Neural stem cells for Parkinson's disease: To protect and repair. Proc Natl Acad Sci USA (2007) 104(29):11869-11870.
89. Park KI, Teng YD, Snyder EY: The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol (2002) 20(11):1111-1117.
90. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R: Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking recovery of progenitor cells. Nat Biotechnol (2000) 18(4):410-414.
91. Brekke C, Williams SC, Price J, Thorsen F, Modo M: Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model. Neuroimage (2007) 37(3):769-782.
92. Lin D, Najbauer J, Salvaterra PM, Mamelak AN, Barish ME, Garcia E, Metz MZ, Kendall SE, Bowers M, Kateb B, Kim SU et al: Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma. Neuroimage (2007) 37(Suppl 1):S18-S26.
93. Yuan X, Hu J, Belladonna ML, Black KL, Yu JS: Interleukin-23- expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res (2006) 66(5):2630- 2638.
94. Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM, Carroll RS: Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res (2006) 12(18):5550-5556.
95. Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, Justus KA, Phelps DA, Remack JS, Yoon KJ, Gillespie S, Kim SU et al: Development of a tumor-selective approach to treat metastatic cancer. PLoS ONE (2006) 1:e23.